|
⚲
|
| Keyboard |
| Caudill Cortney
✚
|
|
|---|---|
| CIK # | 0002090209 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002090209] | |
| 4 | [0002090209] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Caudill Cortney | |
| Halozyme Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-10 | Option exercise | 1,546 | $33.51 | 51,806 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-10 | Sell | 8,857 | $67.64 | 599,087 |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock · derivative
|
2026-03-10 | Option exercise | 1,546 | $33.51 | 51,806 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-09 | Option exercise | 20,000 | $33.51 | 670,200 |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock · derivative
|
2026-03-09 | Option exercise | 20,000 | $33.51 | 670,200 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-09 | Sell | 2,100 | $68.25 | 143,325 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-09 | Sell | 17,900 | $67.75 | 1,212,725 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-20 | Option exercise | 2,666 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-20 | Tax withheld | 1,037 | $70.98 | 73,606 |
|
Halozyme Therapeutics Inc HALO
Restricted Stock Units · derivative
|
2026-02-20 | Option exercise | 2,666 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Performance Stock Units · derivative
|
2026-02-09 | Grant | 2,403 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Restricted Stock Units · derivative
|
2026-02-09 | Grant | 13,047 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock · derivative
|
2026-02-09 | Grant | 14,047 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Performance Stock Units · derivative
|
2026-02-09 | Grant | 14,751 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2025-11-01 | Option exercise | 9,326 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2025-11-01 | Sell | 4,263 | $65.19 | 277,905 |
|
Halozyme Therapeutics Inc HALO
Restricted Stock Units · derivative
|
2025-11-01 | Option exercise | 9,326 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Restricted Stock Units · derivative
|
2025-10-03 | Grant | 3,625 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock · derivative
|
2025-10-03 | Grant | 9,031 | $0.00 |